Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1682
    +0.0025 (+0.22%)
     
  • GBP/USD

    1.2497
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    51,260.92
    -486.86 (-0.94%)
     
  • CMC Crypto 200

    1,332.51
    -64.03 (-4.58%)
     
  • S&P 500

    5,109.41
    +60.99 (+1.21%)
     
  • DOW

    38,321.49
    +235.69 (+0.62%)
     
  • CRUDE OIL

    83.93
    +0.36 (+0.43%)
     
  • GOLD FUTURES

    2,350.00
    +7.50 (+0.32%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Segment-Wise Expectations for Novartis in Q2 2018

Segment-Wise Expectations for Novartis in Q2 2018

Analysts expect Novartis’s (NVS) second-quarter revenues to increase ~6.1% to ~$12.99 billion following growth in its operating revenues across all three segments. The chart below compares the company’s actual quarterly revenues since the first quarter of 2017 and analysts’ estimates for the second quarter.